Literature DB >> 30460429

APC-Cdh1 Regulates Neuronal Apoptosis Through Modulating Glycolysis and Pentose-Phosphate Pathway After Oxygen-Glucose Deprivation and Reperfusion.

Zuofan Li1, Bo Zhang1, Wenlong Yao1, Chuanhan Zhang1, Li Wan1, Yue Zhang2.   

Abstract

Anaphase-promoting complex (APC) with its coactivator Cdh1 is required to maintain the postmitotic state of neurons via degradation of Cyclin B1, which aims to prevent aberrant cell cycle entry that causes neuronal apoptosis. Interestingly, evidence is accumulating that apart from the cell cycle, APC-Cdh1 also involves in neuronal metabolism via modulating the glycolysis promoting enzyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3). Here, we showed that under oxygen-glucose deprivation and reperfusion (OGD/R), APC-Cdh1 was decreased in primary cortical neurons. Likewise, the neurons exhibited enhanced glycolysis when oxygen supply was reestablished during reperfusion, which was termed as the "neuronal Warburg effect." In particular, the reperfused neurons showed elevated PFKFB3 expression in addition to a reduction in glucose 6-phosphate dehydrogenase (G6PD). Such changes directed neuronal glucose metabolism from pentose-phosphate pathway (PPP) to aerobic glycolysis compared to the normal neurons, resulting in increased ROS production and apoptosis during reperfusion. Pretreatment of neurons with Cdh1 expressing lentivirus before OGD could reverse this metabolic shift and attenuated ROS-induced apoptosis. However, the metabolism regulation and neuroprotection by Cdh1 under OGD/R condition could be blocked when co-transfecting neurons with Ken box-mut-PFKFB3 (which is APC-Cdh1 insensitive). Based on these data, we suggest that the Warburg effect may contribute to apoptotic mechanisms in neurons under OGD/R insult, and targeting Cdh1 may be a potential therapeutic strategy as both glucose metabolic regulator and apoptosis suppressor of neurons in brain injuries.

Entities:  

Keywords:  Aerobic glycolysis; Cdh1; Neuron; Oxygen-glucose deprivation; Pentose-phosphate pathway

Mesh:

Substances:

Year:  2018        PMID: 30460429     DOI: 10.1007/s10571-018-0638-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  45 in total

Review 1.  Ischemic injury and faulty gene transcripts in the brain.

Authors:  P K Liu; R G Grossman; C Y Hsu; C S Robertson
Journal:  Trends Neurosci       Date:  2001-10       Impact factor: 13.837

2.  Nuclear localization of the cell cycle regulator CDH1 and its regulation by phosphorylation.

Authors:  Yuan Zhou; Yick-Pang Ching; Abel C S Chun; Dong-Yan Jin
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

3.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.

Authors:  Tarig Bashir; N Valerio Dorrello; Virginia Amador; Daniele Guardavaccaro; Michele Pagano
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

Review 4.  Brain work and brain imaging.

Authors:  Marcus E Raichle; Mark A Mintun
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

5.  Cell-intrinsic regulation of axonal morphogenesis by the Cdh1-APC target SnoN.

Authors:  Judith Stegmüller; Yoshiyuki Konishi; Mai Anh Huynh; Zengqiang Yuan; Sara Dibacco; Azad Bonni
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

6.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in rat brain.

Authors:  F Ventura; J L Rosa; S Ambrosio; J Gil; R Bartrons
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

7.  Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection.

Authors:  Paula García-Nogales; Angeles Almeida; Juan P Bolaños
Journal:  J Biol Chem       Date:  2002-10-31       Impact factor: 5.157

8.  Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons.

Authors:  C Gieffers; B H Peters; E R Kramer; C G Dotti; J M Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 9.  Reactive oxygen radicals in signaling and damage in the ischemic brain.

Authors:  P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-01       Impact factor: 6.200

10.  Cell cycle-dependent nuclear export of Cdh1p may contribute to the inactivation of APC/C(Cdh1).

Authors:  Malika Jaquenoud; Frank van Drogen; Matthias Peter
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

View more
  5 in total

1.  De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies.

Authors:  Sathiya N Manivannan; Jolien Roovers; Noor Smal; Candace T Myers; Dilsad Turkdogan; Filip Roelens; Oguz Kanca; Hyung-Lok Chung; Tasja Scholz; Katharina Hermann; Tatjana Bierhals; Hande S Caglayan; Hannah Stamberger; Heather Mefford; Peter de Jonghe; Shinya Yamamoto; Sarah Weckhuysen; Hugo J Bellen
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

2.  Overexpression of miR-124 Protects Against Neurological Dysfunction Induced by Neonatal Hypoxic-Ischemic Brain Injury.

Authors:  Liulin Xiong; Haoli Zhou; Manxi He; Tinghua Wang; Qiong Zhao; Lulu Xue; Mohammed Al-Hawwas; Jingyuan He; Maxiu Wu; Yu Zou; Mingan Yang; Jing Dai
Journal:  Cell Mol Neurobiol       Date:  2020-01-08       Impact factor: 5.046

Review 3.  Effects of Oxidative Stress on Protein Translation: Implications for Cardiovascular Diseases.

Authors:  Arnab Ghosh; Natalia Shcherbik
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

Review 4.  The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer.

Authors:  Hung-Chi Yang; Yi-Hsuan Wu; Wei-Chen Yen; Hui-Ya Liu; Tsong-Long Hwang; Arnold Stern; Daniel Tsun-Yee Chiu
Journal:  Cells       Date:  2019-09-08       Impact factor: 6.600

5.  Cardioprotective Natural Compound Pinocembrin Attenuates Acute Ischemic Myocardial Injury via Enhancing Glycolysis.

Authors:  Yanjun Zheng; Guoqing Wan; Bo Yang; Xuefeng Gu; Jingrong Lin
Journal:  Oxid Med Cell Longev       Date:  2020-10-15       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.